Literature DB >> 17192948

Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? No. One size does not fit all: an argument against the routine use of radiation therapy for all patients with ductal carcinoma in situ of the breast who elect breast conservation.

Melvin J Silverstein, Michael D Lagios.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17192948     DOI： 10.1002/jso.20708

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  4 in total

1.  Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.

Authors:  Christopher J Vandenbussche; Nagi Khouri; Eman Sbaity; Theodore N Tsangaris; Russell Vang; Armanda Tatsas; Ashley Cimino-Mathews; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

Review 2.  Cancer Immunoprevention: Current Status and Future Directions.

Authors:  Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-27       Impact factor: 4.291

3.  Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience.

Authors:  B Cutuli; C Lemanski; A Fourquet; B de Lafontan; S Giard; A Meunier; R Pioud-Martigny; F Campana; H Marsiglia; S Lancrenon; E Mery; F Penault-Llorca; E Fondrinier; C Tunon de Lara
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

4.  The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.

Authors:  Onur Gilleard; Andrew Goodman; Martin Cooper; Mary Davies; Julie Dunn
Journal:  World J Surg Oncol       Date:  2008-06-18       Impact factor: 2.754
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.